EP Patent

EP0003002B1 — Verwendung von aromatisch-aliphatischen Ketonen als Photoinitiatoren, photopolymerisierbare Systeme enthaltend solche Ketone und neue aromatisch-aliphatische Ketone

Assigned to BASF Schweiz AG · Expires 1984-06-13 · 42y expired

What this patent protects

Patent listed against bupropion-hydrobromide.

Drugs covered by this patent

bupropion-hydrobromide (BUPROPION HYDROBROMIDE)

Patent Metadata

Patent number: EP0003002B1
Jurisdiction: EP
Classification: —
Expires: 1984-06-13
Drug substance claim: No
Drug product claim: No
Assignee: BASF Schweiz AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.